SE8002602L - Diagnostiskt forfarande - Google Patents

Diagnostiskt forfarande

Info

Publication number
SE8002602L
SE8002602L SE8002602A SE8002602A SE8002602L SE 8002602 L SE8002602 L SE 8002602L SE 8002602 A SE8002602 A SE 8002602A SE 8002602 A SE8002602 A SE 8002602A SE 8002602 L SE8002602 L SE 8002602L
Authority
SE
Sweden
Prior art keywords
serum
dna
cancer
diagnostic procedure
human beings
Prior art date
Application number
SE8002602A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Inventor
S T Crooke
L Galvan
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8002602L publication Critical patent/SE8002602L/

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4704—Inhibitors; Supressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Sink And Installation For Waste Water (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE8002602A 1979-04-10 1980-04-03 Diagnostiskt forfarande SE8002602L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2873279A 1979-04-10 1979-04-10

Publications (1)

Publication Number Publication Date
SE8002602L true SE8002602L (sv) 1980-12-09

Family

ID=21845111

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8002602A SE8002602L (sv) 1979-04-10 1980-04-03 Diagnostiskt forfarande

Country Status (24)

Country Link
JP (1) JPS55143441A (fr)
KR (1) KR830002502A (fr)
AR (1) AR222700A1 (fr)
AT (1) AT365343B (fr)
AU (1) AU536522B2 (fr)
BE (1) BE882669A (fr)
CH (1) CH644453A5 (fr)
DE (1) DE3013837A1 (fr)
DK (1) DK149980A (fr)
ES (1) ES490396A0 (fr)
FI (1) FI801078A (fr)
FR (1) FR2454099A1 (fr)
GB (1) GB2047712B (fr)
GR (1) GR67692B (fr)
HU (1) HU183122B (fr)
IE (1) IE49981B1 (fr)
IL (1) IL59772A (fr)
IT (1) IT1143135B (fr)
LU (1) LU82345A1 (fr)
NL (1) NL8002094A (fr)
NO (1) NO801018L (fr)
PH (1) PH15637A (fr)
SE (1) SE8002602L (fr)
ZA (1) ZA802141B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524644A1 (de) * 1985-07-10 1987-01-15 Heyl Chem Pharm Undulin und dessen peptidfragmente, verfahren zu deren herstellung und ihre verwendung

Also Published As

Publication number Publication date
AU536522B2 (en) 1984-05-10
AU5719380A (en) 1980-10-16
GB2047712B (en) 1983-02-23
FR2454099B1 (fr) 1984-01-27
HU183122B (en) 1984-04-28
IE800693L (en) 1980-10-10
NL8002094A (nl) 1980-10-14
DK149980A (da) 1980-10-11
FI801078A (fi) 1980-10-11
GB2047712A (en) 1980-12-03
DE3013837A1 (de) 1980-10-30
ZA802141B (en) 1981-04-29
ES8103380A1 (es) 1981-02-16
ATA195780A (de) 1981-05-15
AT365343B (de) 1982-01-11
IT1143135B (it) 1986-10-22
NO801018L (no) 1980-10-13
ES490396A0 (es) 1981-02-16
IT8048370A0 (it) 1980-04-09
KR830002502A (ko) 1983-05-30
FR2454099A1 (fr) 1980-11-07
GR67692B (fr) 1981-09-07
IE49981B1 (en) 1986-01-22
IL59772A (en) 1983-05-15
AR222700A1 (es) 1981-06-15
PH15637A (en) 1983-03-11
IL59772A0 (en) 1980-06-30
JPS55143441A (en) 1980-11-08
BE882669A (fr) 1980-10-06
CH644453A5 (fr) 1984-07-31
LU82345A1 (fr) 1980-12-16

Similar Documents

Publication Publication Date Title
ATE196549T1 (de) Immunochemischer nachweiss von endprodukten der fortgeschrittenen glycosylation in vivo
SE8000469L (sv) Vevnadsbindmedel och forfarande for dess framstellning samt bindmedlets anvendning
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
SE8601135L (sv) Kemiskt modifierat hyaluronsyrapreparat och metod for utvinning derav ur djurvevnader
SE8902376D0 (sv) Foerfarande foer framstaellning av ett vaevnadsbindemedel
DK524187D0 (da) Aminosyrechelaterede midler til udlevering til specifikke biologiske vaevssteder
DE69131847D1 (de) Verwendung von kupfer enthaltenden wirkstoffen zur beschleunigung der wundheilung
DE3587941D1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
DE3880047D1 (de) Zusammensetzung eines zusatzes.
ZA872166B (en) Synthetic htlv-iii peptides,compositions and uses thereof
IT7928370A0 (it) Procedimento per determinare l'emoglobina glicosilata in campioni di sangue.
BR8504469A (pt) Componentes acrescentados ao concreto
IT7829543A0 (it) Metodo e composizioni per la determinazione diretta del ferro nel siero ematico.
ATE120372T1 (de) Antikörper für die antilymphozyten- antikörpertherapie.
ATE13767T1 (de) Protein (pp16), verfahren zu seiner anreicherung und gewinnung sowie seine verwendung.
ES511982A0 (es) "procedimiento para la preparacion de plasminogeno practicamente exento de virus de hepatitis".
FI925696A (fi) Pao hirudinets aminosyrasekvens baserade trombininhibitorer
DE69129747D1 (de) In lösung bringen von proteinen in aktiver form
SE8002602L (sv) Diagnostiskt forfarande
NO173336C (no) Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
FI885025A (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
ES8505915A1 (es) Metodo de preparar dimetiloctenonas
ATE77102T1 (de) Verfahren zur reinigung sowie pasteurisierung von urokinase.
DE3686684D1 (de) Mittel zur absorptionsverbesserung von proteinen.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8002602-4